Equities

Epsilon Healthcare Ltd

Epsilon Healthcare Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.024
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change-11.11%
  • Beta1.2266
Data delayed at least 20 minutes, as of Dec 18 2023.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Epsilon Healthcare Limited is an Australia-based global healthcare and pharmaceuticals company. The Company has a diversified and vertically integrated portfolio of assets, including healthcare and pharmaceutical contract development and manufacturing. The Company’s segments include the manufacture and distribution of hydroponics equipment, materials and nutrients, and the development and delivery of medicinal cannabis. The Company owns medicinal cannabis assets, including the GMP cannabis manufacturing facility in the Southern Hemisphere (the Southport Facility) in Southport, Australia, and the Tetra Health clinic group. The Company also provides advisory services related to medicinal cannabis. The Company’s subsidiaries include Dragon Vision Limited, Canndeo Pty Ltd, Canna Clinics Pty Ltd, THC Pharma Pty Ltd, Metra Holdings Pty Ltd, Tetra Pty Ltd, Medimar Pty Ltd and Demimar Pty Ltd.

  • Revenue in AUD (TTM)7.21m
  • Net income in AUD-5.93m
  • Incorporated2016
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Imagion Biosystems Ltd1.94m-6.32m1.46m--------0.7526-0.1975-0.19750.0604-0.16160.6283--18.04---204.15-77.35---92.61-----324.91-1,165.21---10.76----152.0731.06-27.19--17.90--
Hydration Pharmaceuticals Co Ltd14.92m-11.81m5.18m--------0.3474-0.0472-0.04720.056-0.01391.491.566.38---117.74-79.98-251.39-111.5756.0048.73-79.18-99.530.8282-4.392.42--10.3419.2723.61------
Nutritional Growth Solutions Ltd4.17m-4.14m5.82m--------1.40-0.1712-0.17120.1722-0.08772.082.3633.46---206.84------22.3642.47-99.30-152.300.0943-57.50----1.2641.6131.91------
TrivarX Ltd893.31k-1.43m6.86m4.00--0.6211--7.67-0.0045-0.00450.00270.02420.0935-------15.02-37.57-17.67-43.65100.0092.56-160.59-446.23---105.740.0016---6.99-26.3953.28--17.61--
Epsilon Healthcare Ltd7.21m-5.93m7.21m----0.7868--0.9994-0.0198-0.01980.02410.03050.383917.942.73---31.54-35.68-46.30-41.1137.9926.88-82.17-197.560.5237-9.280.2329--29.3630.99-43.77--8.14--
Firebrick Pharma Ltd14.52k-1.18m10.93m----4.33--752.45-0.0066-0.00660.000080.0120.0054--0.0267---43.64-98.70-51.22-109.33-156.89---8,098.28-80,697.286.36--0.00--1,649.40--82.71------
Anatara Lifesciences Ltd0.00-1.45m11.19m----8.12-----0.0098-0.00980.000.00710.00-------93.91-76.37-126.61-88.90------------0.00------28.27------
Argent BioPharma Ltd891.08k-17.53m12.48m--------14.01-0.5116-0.51160.0241-0.11380.08580.61441.77---168.97-129.61---254.2822.86-27.15-1,969.34-667.990.1532-37.54-----73.706.3115.81---17.96--
Acrux Ltd8.10m-5.80m13.37m43.00--4.08--1.65-0.02-0.020.0280.01130.728--2.61---52.14-45.05-71.89-54.0451.14---71.62-114.01----0.5307---32.118.91-659.16---6.20--
Althea Group Holdings Ltd30.37m-32.06m16.21m----51.78--0.5338-0.0858-0.08580.08080.00080.84382.347.03---89.06-37.78-167.97-47.1360.7053.83-105.54-94.470.4086-4.080.9466--20.8799.01-133.57---25.27--
Immuron Ltd4.90m-6.94m17.19m6.00--1.35--3.51-0.0304-0.03040.02150.05570.26121.295.43---36.96-27.01-42.53-29.3368.0674.23-141.49-245.534.87-3.030.0032--171.6715.48-83.20---37.22--
Calmer Co International Ltd4.26m-3.73m17.64m--------4.14-0.0035-0.00350.0038-0.00031.132.019.14---98.45-119.20-395.42-195.4949.6239.01-87.42-219.690.5607-12.301.27--138.9287.7928.91---20.42--
Nyrada Inc3.40m-1.39m22.01m----3.79--6.47-0.0081-0.00810.02090.02770.6147-------25.13-53.28-29.75-62.52-----40.89-236.15----0.00--115.5546.4282.12------
Data as of Dec 18 2023. Currency figures normalised to Epsilon Healthcare Ltd's reporting currency: Australian Dollar AUD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.